- $28.20bn
- $45.25bn
- $9.64bn
- 52
- 85
- 86
- 87
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 4,130 | 3,866 | 3,825 | 5,822 | 7,115 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 3,954 | 3,866 | 3,825 | 5,305 | 6,470 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 2,547 | 1,770 | 2,455 | 2,611 | 3,619 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,929 | 1,353 | 1,859 | 1,992 | 2,741 |
Net Income Before Extraordinary Items | |||||
Net Income | 1,929 | 1,353 | 1,859 | 1,992 | 2,741 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 1,850 | 1,279 | 1,777 | 1,891 | 2,636 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 13.8 | 14.7 | 13.6 | 13.1 | 15.8 |
Dividends per Share |